3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Genitourinary
1
Gastrointestinal
1
Breast
1
Conditions
Breast Neoplasms
152
Neoplasm Metastasis
22
Neoplasms
21
Ovarian Neoplasms
12
Sarcoma
10
Pancreatic Neoplasms
9
Squamous Cell Carcinoma of Head and Neck
8
Melanoma
7
Endometrial Neoplasms
7
Colorectal Neoplasms
7
Carcinoma, Non-Small-Cell Lung
7
Prostatic Neoplasms
6
Precursor Cell Lymphoblastic Leukemia-Lymphoma
6
Multiple Myeloma
6
Lymphoma, Non-Hodgkin
6
Head and Neck Neoplasms
6
Carcinoma, Renal Cell
6
Recurrence
5
Medulloblastoma
5
Lung Neoplasms
5
Leukemia, Myeloid, Acute
5
Breast Diseases
5
Triple Negative Breast Neoplasms
4
Sarcoma, Ewing
4
Neoplasms by Site
4
Lymphoma, Mantle-Cell
4
Liposarcoma
4
Glioma
4
Glioblastoma
4
Colonic Neoplasms
4
Interventions
Dalteparin
4
Saline Solution
3
Gemcitabine
3
Enoxaparin
3
Warfarin
2
Tinzaparin
2
Heparin, Low-Molecular-Weight
2
Fondaparinux
2
Aspirin
2
130-nm albumin-bound paclitaxel
2
palbociclib
1
isoquercitrin
1
enoxaparin sodium
1
edoxaban
1
apixaban
1
alvocidib
1
Tranexamic Acid
1
Sodium Chloride
1
Sodium Bicarbonate
1
Rivaroxaban
1
Pentetic Acid
1
PEGPH20
1
Nadroparin
1
Minocycline
1
Ketoconazole
1
Heparin
1
Fluorodeoxyglucose F18
1
Fluoridation
1
Estramustine
1
Doxorubicin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Thromboembolism
×
palbociclib
×
Clear all
NCT06065592
2023-10-06
CAT_PB
Lebanese University
Phase 1
Unknown
500 enrolled